ArticleClinical, cosmetic and investigational dermatology2026
Atypical Fibroxanthoma on the Scalp of a 74-Year-Old Male with an Incidental Finding of an Amelanotic Melanoma on the Back.
Article in Clinical, cosmetic and investigational dermatology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Atypical fibroxanthoma (AFX) is a rare spindle-cell tumor of the skin, typically occurring in sun-exposed areas of elderly patients. We report an unusual case of synchronous AFX and amelanotic melanoma in a 74-year-old man. The patient presented with a 7-month history of a bleeding nodule on the scalp. Clinical examination revealed an 18 mm red nodule in diameter with hemorrhagic crust. An additional 23 mm pink-red bleeding nodule in diameter on the back, previously unnoticed by the patient, was also identified. Both lesions were excised with 3-5 mm margins. Histopathological and immunohistochemical analysis of the scalp tumor showed a dermal proliferation of atypical spindle cells with high mitotic activity, Ki-67 expression of approximately 35%, SMA positivity, and negativity for melanocytic and epithelial markers, supporting the diagnosis of AFX. In contrast, the second lesion demonstrated melanocytic markers (Melan A, HMB-45, S-100 positivity), with Breslow thickness of 1 mm and Clark level III, consistent with amelanotic melanoma. The patient was referred for further surgical oncological management. At the last available follow-up, 6 months after excision, the patient showed no clinical evidence of local recurrence, nodal involvement, or distant metastasis. This case highlights the importance of thorough skin examination in patients with cutaneous tumors, as multiple distinct malignancies may coexist.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.